These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9659967)

  • 1. Stability of vancomycin in an extemporaneously compounded ophthalmic solution.
    Fuhrman LC; Stroman RT
    Am J Health Syst Pharm; 1998 Jul; 55(13):1386-8. PubMed ID: 9659967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution.
    Anaizi NH; Swenson CF; Dentinger PJ
    Am J Health Syst Pharm; 1997 Mar; 54(5):549-53. PubMed ID: 9066864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Storage of extemporaneously prepared ophthalmic antimicrobial solutions.
    Charlton JF; Dalla KP; Kniska A
    Am J Health Syst Pharm; 1998 Mar; 55(5):463-6. PubMed ID: 9522930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fortified antibiotic (vancomycin, amikacin and ceftazidime) eye drop stability assessment at -20 degrees C].
    Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
    J Fr Ophtalmol; 2007 Oct; 30(8):807-13. PubMed ID: 17978677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months.
    Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
    Cornea; 2010 Jul; 29(7):807-11. PubMed ID: 20489598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
    Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
    Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of fortified cefazolin ophthalmic solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives.
    Rojanarata T; Tankul J; Woranaipinich C; Potawanich P; Plianwong S; Sakulma S; Saehuan C
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):485-90. PubMed ID: 20879806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product.
    Huvelle S; Godet M; Hecq JD; Gillet P; Jamart J; Galanti LM
    Int J Pharm Compd; 2016; 20(4):347-350. PubMed ID: 28333681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of frozen 1% voriconazole ophthalmic solution.
    Amorós-Reboredo P; Bastida-Fernandez C; Guerrero-Molina L; Soy-Muner D; López-Cabezas C
    Am J Health Syst Pharm; 2015 Mar; 72(6):479-82. PubMed ID: 25736943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles.
    Ahmed I; Day P
    Am J Hosp Pharm; 1987 Oct; 44(10):2287-90. PubMed ID: 3687969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of deep freezing on the stability of 25 mg/ml vancomycin ophthalmic solutions.
    Sautou-Miranda V; Libert F; Grand-Boyer A; Gellis C; Chopineau J
    Int J Pharm; 2002 Mar; 234(1-2):205-12. PubMed ID: 11839451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility and stability of aztreonam and vancomycin hydrochloride.
    Trissel LA; Xu QA; Martinez JF
    Am J Health Syst Pharm; 1995 Nov; 52(22):2560-4. PubMed ID: 8590240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term stability of vancomycin hydrochloride in intravenous infusions.
    Galanti LM; Hecq JD; Vanbeckbergen D; Jamart J
    J Clin Pharm Ther; 1997; 22(5-6):353-6. PubMed ID: 19160720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of tacrolimus ophthalmic solution.
    Ezquer-Garin C; Ferriols-Lisart R; Alós-Almiñana M
    Am J Health Syst Pharm; 2017 Jul; 74(13):1002-1006. PubMed ID: 28645998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days.
    Roura-Turet J; Rodriguez-Reyes M; Guerrero-Molina L; Soy-Muner D; López-Cabezas C
    Am J Health Syst Pharm; 2021 Jul; 78(15):1444-1447. PubMed ID: 33950182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of fumagillin in an extemporaneously prepared ophthalmic solution.
    Abdel-Rahman SM; Nahata MC
    Am J Health Syst Pharm; 1999 Mar; 56(6):547-50. PubMed ID: 10192690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of extemporaneously prepared voriconazole ophthalmic solution.
    Al-Badriyeh D; Li J; Stewart K; Kong DC; Leung L; Davies GE; Fullinfaw R
    Am J Health Syst Pharm; 2009 Aug; 66(16):1478-83. PubMed ID: 19667005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of extemporaneously prepared ophthalmic solutions for mydriasis.
    Camp NA; Nadra JT; Hughes SE; Gilbert JM; Zhao F
    Am J Health Syst Pharm; 2018 May; 75(9):e231-e235. PubMed ID: 29691266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic lock: in vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37 degrees C.
    Battistella M; Walker S; Law S; Lok C
    Hemodial Int; 2009 Jul; 13(3):322-8. PubMed ID: 19493023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.